2 -Adrenoceptor regulation of adenylyl cyclase in CHO cells: Dependence on receptor density, receptor subtype and current activity of adenylyl cyclase

By Pohjanoksa K.   Jansson C.c.   Luomala K.   Marjamaki A.   Savola J.-M.   Scheinin M.  

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 53-63

Elsevier

Access to resources Recommend Favorite

Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment

By Jensen J.B.   Mikkelsen J.D.   Mork. A.  

European Neuropsychopharmacology, Vol. 10, Iss. 2, 2000-03 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite

Evidence that atypical vasopressin V 2 receptor in inner medulla of kidney is V 1B receptor

By Saito M.   Tahara A.   Sugimoto T.   Abe K.   Furuichi K.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 289-296

Elsevier

Access to resources Recommend Favorite

P2 receptor-mediated inhibition of adenylyl cyclase in PC12 cells

By Murayama T.   Yakushi Y.   Watanabe A.   Nomura Y.  

European Journal of Pharmacology, Vol. 348, Iss. 1, 1998-05 ,pp. : 71-76

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro characterisation of a nonpeptide vasopressin V 1A and V 2 receptor antagonist (YM087) in the rat

By Risvanis J.   Naitoh M.   Johnston C.I.   Burrell L.M.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite